According to filings with the U.S. Securities and Exchange Commission, Acclinate is raising up to $7,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Delmonize Smith played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Acclinate
Our vision is health equity through inclusive research. We help pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive. Connect better with communities of color and increase diversity in clinical research through community engagement and predictive insights. Acclinate turns trust and data into better representation. With more than 100,000 community members and relationships with some of the largest healthcare companies, we have successfully mobilized individuals to take action at a higher rate than companies like us.

To learn more about Acclinate, visit http://www.acclinate.com/

Contact:
Delmonize Smith, President and Chief Executive Officer
256-210-4297
https://www.linkedin.com/in/delmonize/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.